Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to evaluate treatment response to neoadjuvant chemoradiotherapy (CRT) with regard to mucin status in pathology and pretreatment magnetic resonance imaging (MRI) in locally advanced rectal cancer. Materials and Methods Between 2003 and 2011, 306 patients with locally advanced rectal cancer received neoadjuvant CRT followed by surgery, and mucinous adenocarcinoma (MAC) was found in 27 (8.8%). All MAC patients had MRI before and after CRT and mucin proportion at MRI was measured. Therapeutic response was assessed by pathology after total mesorectal excision. To determine the optimal cut-off for mucin proportion in predicting good CRT response (near total or total regression) and negative circumferential resection margin (CRM), the receiveroperating characteristic analysis was performed. Results After neoadjuvant CRT, overall downstaging occurred in 44.4% of MAC and 72.4% of non- MAC (p=0.001), and positive CRM (! 1 mm) was observed more frequently in MAC (p < 0.001). The optimal threshold for treatment response was 30% for mucin proportion, and there are nine with low mucin proportion (< 30%) and 18 with high mucin proportion (" 30%) in pretreatment MRI. Negative CRM and tumor downstaging occurred more common in patients with mucin < 30%, although statistically insignificant (p=0.071 and p=0.072, respectively). Regarding oncologic outcomes, lower mucin proportion in pretreatment MRI was associated with better disease-free and overall survival in MAC group (p=0.092 and 0.056, respectively), but the difference did not reach statistical significance. Conclusion Poor treatment outcome with neoadjuvant CRT was observed in patients with MAC, especially those with high mucin proportion at pretreatment MRI.
Abstract
Purpose The purpose of this study was to evaluate treatment response to neoadjuvant chemoradiotherapy (CRT) with regard to mucin status in pathology and pretreatment magnetic resonance imaging (MRI) in locally advanced rectal cancer. Materials and Methods Between 2003 and 2011, 306 patients with locally advanced rectal cancer received neoadjuvant CRT followed by surgery, and mucinous adenocarcinoma (MAC) was found in 27 (8.8%). All MAC patients had MRI before and after CRT and mucin proportion at MRI was measured. Therapeutic response was assessed by pathology after total mesorectal excision. To determine the optimal cut-off for mucin proportion in predicting good CRT response (near total or total regression) and negative circumferential resection margin (CRM), the receiveroperating characteristic analysis was performed. Results After neoadjuvant CRT, overall downstaging occurred in 44.4% of MAC and 72.4% of non- MAC (p=0.001), and positive CRM (! 1 mm) was observed more frequently in MAC (p < 0.001). The optimal threshold for treatment response was 30% for mucin proportion, and there are nine with low mucin proportion (< 30%) and 18 with high mucin proportion (" 30%) in pretreatment MRI. Negative CRM and tumor downstaging occurred more common in patients with mucin < 30%, although statistically insignificant (p=0.071 and p=0.072, respectively). Regarding oncologic outcomes, lower mucin proportion in pretreatment MRI was associated with better disease-free and overall survival in MAC group (p=0.092 and 0.056, respectively), but the difference did not reach statistical significance. Conclusion Poor treatment outcome with neoadjuvant CRT was observed in patients with MAC, especially those with high mucin proportion at pretreatment MRI.
참고문헌 (29)
- Compton CC, "Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999", Arch Pathol Lab Med, 124, pp.979~994 (2000)
- Verhulst J, "Mucinous subtype as prognostic factor in colorectal cancer : a systematic review and meta-analysis", J Clin Pathol, 65, pp.381~388 (2012)
- Hanski C., "Is mucinous carcinoma of the colorectum a distinct genetic entity?", Br J Cancer, 72, pp.1350~1356 (1995)
- Halvorsen TB, "Influence of mucinous components on survival in colorectal adenocarcinomas : a multivariate analysis", J Clin Pathol, 41, pp.1068~1072 (1988)
- Hermanek P, "Prognostic factors in rectal carcinoma : a contribution to the further development of tumor classification", Dis Colon Rectum, 32, pp.593~599 (1989)
- Hugen N, "Modern treatment of rectal cancer closes the gap between common adenocarcinoma and mucinous carcinoma", Ann Surg Oncol, 22, pp.2669~2676 (2015)
- Simha V, "Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?", J Gastrointest Oncol, 5, pp.276~279 (2014)
- Shin US, "Mucinous rectal cancer : effectiveness of preoperative chemoradiotherapy and prognosis", Ann Surg Oncol, 18, pp.2232~2239 (2011)
- Grillo-Ruggieri F, "Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy", Dis Colon Rectum, 50, pp.1594~1603 (2007)
- Kim MJ, "Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging", J Comput Assist Tomogr, 27, pp.48~55 (2003)
- Oberholzer K, "Rectal cancer : mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation", Int J Radiat Oncol Biol Phys, 82, pp.842~848 (2012)
- 장희진, "대장암 병리보고서 기재사항 표준화", Journal of Pathology and Translational Medicine, 40(3), pp.193~203 (2006), 대한병리학회
- McCawley N, "Mucinous rectal adenocarcinoma is associated with a poor response to neoadjuvant chemoradiotherapy : a systematic review and meta-analysis", Dis Colon Rectum, 59, pp.1200~1208 (2016)
- Hyngstrom JR, "Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma : analysis from the National Cancer Data Base", Ann Surg Oncol, 19, pp.2814~2821 (2012)
- Hugen N, "Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma", Ann Oncol, 24, pp.2819~2824 (2013)
- Hogan J, "Overall survival is improved in mucinous adenocarcinoma of the colon", Int J Colorectal Dis, 29, pp.563~569 (2014)
- Negri FV, "Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer", Ann Oncol, 16, pp.1305~1310 (2005)
- Catalano V, "Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin-and", or irinotecan-based chemotherapy, 2009, pp.100, 881~887
- Kazama Y, "Mucinous carcinomas of the colon and rectum show higher rates of microsatellite instability and lower rates of chromosomal instability : a study matched for T classification and tumor location", Cancer, 103, pp.2023~2029 (2005)
- Carethers JM, "Mismatch repair proficiency and in vitro response to 5-fluorouracil", Gastroenterology, 117, pp.123~131 (1999)
- Jover R, "Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer", Gut, 55, pp.848~855 (2006)
- Ribic CM, "Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer", N Engl J Med, 349, pp.247~257 (2003)
- Dolcetti R, "High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability", Am J Pathol, 154, pp.1805~1813 (1999)
- Xiao Y, "The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy", Cancer Discov, 5, pp.16~18 (2015)
- Llosa NJ, "The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints", Cancer Discov, 5, pp.43~51 (2015)
- Friedman EJ, "Immune modulation by ionizing radiation and its implications for cancer immunotherapy", Curr Pharm Des, 8, pp.1765~1780 (2002)
- Compton CC, "Key issues in reporting common cancer specimens : problems in pathologic staging of colon cancer", Arch Pathol Lab Med, 130, pp.318~324 (2006)
- Shia J, "Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy", Am J Surg Pathol, 35, pp.127~134 (2011)
- Hussain SM, "Mucinous versus nonmucinous rectal carcinomas : differentiation with MR imaging", Radiology, 213, pp.79~85 (1999)